oxfordbiodynamics, Author at Oxford Biodynamics

Study published in Faculty of 1000 Research identifies epigenetic changes for monitoring disease progression in Huntington's disease (HD)

by oxfordbiodynamics

Leading Chinese Healthcare Investment Group Takes Stake in Oxford Biodynamics Plc

by oxfordbiodynamics

Oxford Biodynamics extending precision medicine study

Oxford Biodynamics extending precision medicine study

by oxfordbiodynamics

Chromosome conformation signatures response to methotrexate in early rheumatoid arthritis.

by oxfordbiodynamics

Oxford BioDynamics signs second collaboration agreement with major US biopharmaceutical company.

by oxfordbiodynamics

Oxford BioDynamics presents latest immunotherapy data at the NIH Biomarker Consortium Cancer Steering Committee Annual Symposium, in Washington, DC.

by oxfordbiodynamics

Oxford BioDynamics signs collaboration agreement with a major US biopharmaceutical company.

by oxfordbiodynamics

Oxford BioDynamics presents at the Diabetes Asia 2017 Conference.

by oxfordbiodynamics

Oxford BioDynamics Advances Epigenetic Signatures for Breast Cancer, ALS.

Read the article

by oxfordbiodynamics

Oxford BioDynamics presents ALS signatures at NEALS.

British Biotech Spots DNA Changes that Help ALS Diagnosis - Labiotech

Oxford BioDynamics Demonstrates Ability To Predict Progression Of ALS - Morningstar

Northland Capital Partners View on the City - Oxford Biodynamics PLC - Proactive Investors

by oxfordbiodynamics